Showing results (231-240 of 443) with videos related to
Sort By:
Pageof 45
Reproduction (Cambridge, England)|March 31, 2005
The PATE gene is expressed in the accessory tissues of the human male genital tract and encodes a secreted sperm-associated proteinAngel A Soler-García, Rangan Maitra, Vasantha Kumar, et al.Hypertension (Dallas, Tex. : 1979)|February 10, 2010
Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independentTaiji Matsusaka, Takako Asano, Fumio Niimura, et al.Biomaterials|August 15, 2013
Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphomaOmmoleila Molavi, Xiao-Bing Xiong, Donna Douglas, et al.Cancer Immunology, Immunotherapy : CII|November 17, 2017
Cancer vaccine strategies: translation from mice to human clinical trialsJay A Berzofsky, Masaki Terabe, Jane B Trepel, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2015
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting GlioblastomaNadja Müller, Susanne Michen, Stefanie Tietze, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2010
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancersRaffit Hassan, Steven J Cohen, Martin Phillips, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostateTapan K Bera, Sudipto Das, Hiroshi Maeda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2005
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignanciesRobert J Kreitman, David R Squires, Maryalice Stetler-Stevenson, et al.Proceedings of the National Academy of Sciences of the United States of America|June 8, 2022
Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical studyGuannan Wang, Alok Kumar, Wanjun Ding, et al.Biochemical and Biophysical Research Communications|November 13, 2007
Expression of POTE protein in human testis detected by novel monoclonal antibodiesTomoko Ise, Sudipto Das, Satoshi Nagata, et al.Pageof 45